Israel Englander Akari Therapeutics PLC Transaction History

Millennium Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.16 - $0.22 $20,343 - $27,972	-127,146 Reduced 48.68%	134,046 $22,000
Q1 2023 May 15, 2023	BUY	$0.15 - $0.54 $30,916 - $111,299	206,111 Added 374.2%	261,192 $47,000
Q4 2022 Feb 14, 2023	BUY	$0.41 - $12.8 $7,190 - $224,473	17,537 Added 46.71%	55,081 $27,000
Q3 2022 Nov 14, 2022	BUY	$0.6 - $12.6 $13,957 - $293,113	23,263 Added 162.89%	37,544 $24,000
Q2 2022 Aug 15, 2022	BUY	$0.95 - $1.22 $13,566 - $17,422	14,281 New	14,281 $14,000
Q4 2021 Feb 14, 2022	SELL	$1.38 - $1.74 $21,080 - $26,580	-15,276 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.59 - $1.87 $24,288 - $28,566	15,276 New	15,276 $25,000
Q3 2020 Nov 16, 2020	SELL	$1.58 - $2.37 $42,813 - $64,219	-27,097 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.16 - $2.61 $31,432 - $70,723	27,097 New	27,097 $59,000
Q1 2019 May 14, 2019	SELL	$1.66 - $5.9 $45,498 - $161,713	-27,409 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.57 - $2.49 $177 - $281	113 Added 0.41%	27,409 $43,000
Q3 2018 Nov 14, 2018	SELL	$1.82 - $2.56 $14,645 - $20,600	-8,047 Reduced 22.77%	27,296 $70,000
Q2 2018 Aug 14, 2018	SELL	$1.77 - $2.28 $239,443 - $308,436	-135,279 Reduced 79.29%	35,343 $69,000
Q1 2018 May 15, 2018	SELL	$1.77 - $4.39 $158,234 - $392,457	-89,398 Reduced 34.38%	170,622 $311,000
Q4 2017 Feb 14, 2018	BUY	$4.08 - $7.4 $589,466 - $1.07 Million	144,477 Added 125.04%	260,020 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$3.42 - $8.74 $395,157 - $1.01 Million	115,543	115,543 $709,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $145M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.